Principal Pharmaceuticals currently manulctures cardiovascular beta blockers such as atenolol and metroprolol tartrate, Its future plans include expansion into the field of ace inhibitors like enalapril, quinapril, rarrilpril and their intermediates, ECPPA.
In the CNS segment the company will developilhalopyridol among other molecules, though not immediately1be company has a manu&cturing unit aq Panoli near Ankleshwar, Gujarat.